The Evaluation of Serum Lipoprotein-associated Phospholipase A2 ,Ischemia Modified Protein and Platelet Activating Factor in the Severity and Prognosis of Ischemic Stroke

LI Lanxin; LI Bo; HE Qianghua; GOU Wei

doi:10.12102/j.issn.1672-1349.2020.23.037

Home>Articles>The Evaluation of Serum Lipoprotein-associated Phospholipase A2 ,Ischemia Modified Protein and Platelet Activating Factor in the Severity and Prognosis of Ischemic Stroke

DOI: 10.12102/j.issn.1672-1349.2020.23.037

The Evaluation of Serum Lipoprotein-associated Phospholipase A2 ,Ischemia Modified Protein and Platelet Activating Factor in the Severity and Prognosis of Ischemic Stroke

LI Lanxin

LI Bo

HE Qianghua

GOU Wei

Machine-generated Keywords：

Publication Date：2020-12-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 4061-4064 )

Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease

ISTIC

ISSN：1672-1349

Year, Vol.(Issue)：2020,18(23)